Avalo Therapeutics, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Todd Foley. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Todd Foley har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ITOS / iTeos Therapeutics, Inc. 2.108.594
US:HOWL / Werewolf Therapeutics, Inc. 10% Owner 3.208.793
US:TRDA / Entrada Therapeutics, Inc. 10% Owner 4.381.062
US:TCRR / Tcr2 Therapeutics Inc 10% Owner 0
US:RPTX / Repare Therapeutics Inc. Director 49.000
Director 0
US:HARP / Harpoon Therapeutics, Inc. 3.220.844
US:RYTM / Rhythm Pharmaceuticals, Inc. Director 909.258
US:ONCR / Oncorus, Inc. 10% Owner 0
10% Owner 0
US:RDUS / Radius Recycling, Inc. 1.427.698
US:SNDX / Syndax Pharmaceuticals, Inc. 10% Owner 0
US:AVTX / Avalo Therapeutics, Inc. 10% Owner 0
US:TRIV / TriVascular Technologies, Inc. 10% Owner 37.369
US:PETX / Aratana Therapeutics, Inc. 10% Owner 2.751.048
US:EPZM / Epizyme Inc 10% Owner 2.413.819
US:CLDN / Celladon Corp Director 17.517
US:CNAT / Conatus Pharmaceuticals Inc. 10% Owner 32.220
US:PCRX / Pacira BioSciences, Inc. 2.790.479
US:ZLCS / Director 15.000
US:VSTM / Verastem, Inc. 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Todd Foley. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AVTX / Avalo Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVTX / Avalo Therapeutics, Inc. Insider Trades
Insidersalg AVTX / Avalo Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVTX / Avalo Therapeutics, Inc. Insider Trades
Insiderkøb HOWL / Werewolf Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-05-04 HOWL MPM BioVentures 2014, L.P. 125.759 16,0000 125.759 16,0000 2.012.144 59 20.3100 542.021 26,94

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HOWL / Werewolf Therapeutics, Inc. Insider Trades
Insidersalg HOWL / Werewolf Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-03-27 HOWL MPM BioVentures 2014, L.P. 1.963 1,0500 1.963 1,0500 2.061 11 0.6300 -824 -40,00

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HOWL / Werewolf Therapeutics, Inc. Insider Trades
Insiderkøb HSTOQ / Histogen Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HSTOQ / Histogen Inc. Insider Trades
Insidersalg HSTOQ / Histogen Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HSTOQ / Histogen Inc. Insider Trades
Insiderkøb PCRX / Pacira BioSciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PCRX / Pacira BioSciences, Inc. Insider Trades
Insidersalg PCRX / Pacira BioSciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2013-03-11 PCRX MPM BioVentures IV QP LP 500.000 27,8600 500.000 27,8600 13.930.000 58 25.84 -1.010.000 -7,25

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PCRX / Pacira BioSciences, Inc. Insider Trades
Insiderkøb RPTX / Repare Therapeutics Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RPTX / Repare Therapeutics Inc. Insider Trades
Insidersalg RPTX / Repare Therapeutics Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-03-12 RPTX Foley Todd 376.412 28,1800 376.412 28,1800 10.607.290 364 12.2100 -6.011.299 -56,67

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RPTX / Repare Therapeutics Inc. Insider Trades
Insiderkøb RYTM / Rhythm Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2018-06-25 RYTM Foley Todd 378.501 26,4200 378.501 26,4200 9.999.996 10 35.85 3.569.265 35,69

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RYTM / Rhythm Pharmaceuticals, Inc. Insider Trades
Insidersalg RYTM / Rhythm Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-03-15 RYTM Foley Todd 1.000.000 25,1000 1.000.000 25,1000 25.100.000 333 6.13 -18.970.000 -75,58

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RYTM / Rhythm Pharmaceuticals, Inc. Insider Trades
Insiderkøb SNDX / Syndax Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades
Insidersalg SNDX / Syndax Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades
Insiderkøb TRDA / Entrada Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRDA / Entrada Therapeutics, Inc. Insider Trades
Insidersalg TRDA / Entrada Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-12-11 TRDA MPM BioVentures 2014, L.P. 21.787 20,2300 21.787 20,2300 440.751 243 5.0200 -331.380 -75,19
2024-12-10 TRDA MPM BioVentures 2014, L.P. 22.935 20,7700 22.935 20,7700 476.360

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRDA / Entrada Therapeutics, Inc. Insider Trades
Insiderkøb VSTM / Verastem, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVTX / Avalo Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2012-02-01 VSTM MPM BIOVENTURES V LLC 100.000 10,0000 8.333 120,0000 1.000.000 43 1729.44 13.411.424 1.341,14

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VSTM / Verastem, Inc. Insider Trades
Insidersalg VSTM / Verastem, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVTX / Avalo Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VSTM / Verastem, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Todd Foley som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-15 2025-05-13 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -630.191 2.108.594 -23,01 8,06 -5.079.339 16.995.268
2025-04-30 2025-03-27 4 HOWL Werewolf Therapeutics, Inc.
Common Stock
S - Sale -1.963 3.208.793 -0,06 1,05 -2.061 3.369.233
2025-04-30 2025-03-27 4 HOWL Werewolf Therapeutics, Inc.
Common Stock
X - Other 22.758 3.210.756 0,71 0,09 2.048 288.968
2024-12-12 2024-12-11 4 TRDA Entrada Therapeutics, Inc.
Common Stock
S - Sale -21.787 4.381.062 -0,49 20,23 -440.751 88.628.884
2024-12-12 2024-12-10 4 TRDA Entrada Therapeutics, Inc.
Common Stock
S - Sale -22.935 4.402.849 -0,52 20,77 -476.360 91.447.174
2023-06-05 2023-06-01 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
J - Other -4.158.964 0 -100,00
2022-05-16 2022-05-13 4 RPTX Repare Therapeutics Inc.
Stock Option (right to buy)
A - Award 49.000 49.000
2022-01-06 2022-01-05 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -18.135 2.738.785 -0,66 42,03 -762.214 115.111.134
2022-01-06 2022-01-04 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -7.671 2.756.920 -0,28 46,47 -356.471 128.114.072
2022-01-06 2022-01-04 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -6.768 2.764.591 -0,24 45,32 -306.726 125.291.264
2022-01-06 2022-01-04 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -19.366 2.771.359 -0,69 43,20 -836.611 119.722.709
2022-01-06 2022-01-04 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale -94.745 2.790.725 -3,28 42,05 -3.984.027 117.349.986
2021-12-07 2021-12-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -1.494 2.885.470 -0,05 34,11 -50.960 98.423.382
2021-12-07 2021-12-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -17.962 2.886.964 -0,62 33,15 -595.440 95.702.857
2021-12-07 2021-12-06 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -60 2.904.926 0,00 35,04 -2.102 101.788.607
2021-12-07 2021-12-06 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -508 2.904.986 -0,02 34,08 -17.313 99.001.923
2021-12-07 2021-12-06 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -1.171 2.905.494 -0,04 33,57 -39.310 97.537.434
2021-12-07 2021-12-06 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -8.469 2.906.665 -0,29 32,35 -273.972 94.030.613
2021-12-07 2021-12-03 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -179 2.915.134 -0,01 36,26 -6.491 105.702.759
2021-12-07 2021-12-03 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -2.419 2.915.313 -0,08 35,44 -85.729 103.318.693
2021-12-07 2021-12-03 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -17.569 2.917.732 -0,60 34,68 -609.293 101.186.946
2021-12-02 2021-12-02 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -7.430 2.935.301 -0,25 34,83 -258.787 102.236.534
2021-12-02 2021-12-02 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -29.757 2.942.731 -1,00 33,74 -1.004.001 99.287.744
2021-12-02 2021-12-01 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -896 2.972.488 -0,03 35,34 -31.665 105.047.726
2021-12-02 2021-12-01 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -5.457 2.973.384 -0,18 34,61 -188.867 102.908.820
2021-12-02 2021-12-01 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -6.042 2.978.841 -0,20 33,82 -204.340 100.744.403
2021-12-02 2021-11-30 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -28.076 2.984.883 -0,93 35,19 -987.994 105.038.033
2021-12-02 2021-11-30 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -5.861 3.012.959 -0,19 34,62 -202.908 104.308.641
2021-11-30 2021-11-29 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -298 3.018.820 -0,01 35,37 -10.540 106.775.663
2021-11-30 2021-11-29 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -10.073 3.019.118 -0,33 34,46 -347.116 104.038.806
2021-11-30 2021-11-26 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -6.129 3.029.191 -0,20 36,03 -220.828 109.141.752
2021-11-30 2021-11-26 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -6.545 3.035.320 -0,22 35,49 -232.282 107.723.507
2021-11-24 2021-11-24 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -13.126 3.041.865 -0,43 37,02 -485.925 112.609.842
2021-11-24 2021-11-24 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -18.343 3.054.991 -0,60 36,05 -661.265 110.132.426
2021-11-24 2021-11-24 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -4.868 3.073.334 -0,16 35,20 -171.354 108.181.357
2021-11-24 2021-11-23 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -359 3.078.202 -0,01 36,50 -13.104 112.354.373
2021-11-24 2021-11-23 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -19.645 3.078.561 -0,63 36,21 -711.345 111.474.694
2021-11-24 2021-11-22 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -11.807 3.098.206 -0,38 37,81 -446.423 117.143.169
2021-11-24 2021-11-22 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -9.307 3.110.013 -0,30 37,16 -345.848 115.568.083
2021-11-24 2021-11-17 4 ITOS iTeos Therapeutics, Inc.
Common Stock
J - Other -15.671 3.119.320 -0,50
2021-11-04 2021-11-02 4 TRDA Entrada Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -3.683.241 0 -100,00
2021-11-04 2021-11-02 4 TRDA Entrada Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -27.617.675 0 -100,00
2021-11-04 2021-11-02 4 TRDA Entrada Therapeutics, Inc.
Common Stock
P - Purchase 100.000 4.425.784 2,31 20,00 2.000.000 88.515.680
2021-11-04 2021-11-02 4 TRDA Entrada Therapeutics, Inc.
Common Stock
C - Conversion 509.024 4.325.784 13,34
2021-11-04 2021-11-02 4 TRDA Entrada Therapeutics, Inc.
Common Stock
C - Conversion 3.816.760 3.816.760
2021-11-01 2021-10-28 4 TRDA Entrada Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 23.552 23.552
2021-10-18 2021-10-18 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -6.167 3.134.991 -0,20 27,14 -167.372 85.083.656
2021-10-18 2021-10-15 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -2.039 3.141.158 -0,06 28,01 -57.112 87.983.836
2021-10-18 2021-10-15 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -8.893 3.143.197 -0,28 27,53 -244.824 86.532.213
2021-10-14 2021-10-14 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -27.320 3.152.090 -0,86 27,30 -745.836 86.052.057
2021-10-14 2021-10-13 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -20.929 3.179.410 -0,65 27,13 -567.804 86.257.393
2021-10-14 2021-10-12 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -8.521 3.200.339 -0,27 27,09 -230.834 86.697.184
2021-10-12 2021-10-11 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -48.812 3.208.860 -1,50 27,24 -1.329.639 87.409.346
2021-10-12 2021-10-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -2.032 3.257.672 -0,06 27,01 -54.884 87.989.721
2021-10-12 2021-10-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -1.149 3.259.704 -0,04 27,00 -31.023 88.012.008
2021-10-05 2021-10-04 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -20.711 3.260.853 -0,63 27,06 -560.440 88.238.682
2021-10-05 2021-10-01 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -6.855 3.281.564 -0,21 27,00 -185.085 88.602.228
2021-09-30 2021-09-30 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -2.292 3.288.419 -0,07 27,00 -61.884 88.787.313
2021-09-30 2021-09-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -19.214 3.290.711 -0,58 27,00 -518.778 88.849.197
2021-09-27 2021-09-27 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -11.625 3.309.925 -0,35 27,09 -314.921 89.665.868
2021-09-27 2021-09-24 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -4.913 3.321.550 -0,15 27,81 -136.631 92.372.306
2021-09-27 2021-09-23 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -717 3.326.463 -0,02 28,38 -20.348 94.405.020
2021-09-27 2021-09-23 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -36.213 3.327.180 -1,08 27,96 -1.012.515 93.027.953
2021-09-23 2021-09-22 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -14.294 3.363.393 -0,42 27,54 -393.657 92.627.843
2021-09-23 2021-09-21 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -19.635 3.377.687 -0,58 27,47 -539.373 92.785.062
2021-09-20 2021-09-20 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -13.701 3.397.322 -0,40 27,84 -381.436 94.581.444
2021-09-20 2021-09-20 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -10.602 3.411.023 -0,31 27,03 -286.572 92.199.952
2021-09-20 2021-09-17 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -45.698 3.421.625 -1,32 28,82 -1.317.016 98.611.232
2021-09-20 2021-09-16 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -21.253 3.467.323 -0,61 28,47 -605.073 98.714.686
2021-09-16 2021-09-15 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -991 3.488.576 -0,03 28,15 -27.897 98.203.414
2021-09-16 2021-09-15 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -23.113 3.489.567 -0,66 27,79 -642.310 96.975.067
2021-09-16 2021-09-14 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -3.623 3.512.680 -0,10 27,99 -101.408 98.319.913
2021-09-16 2021-09-14 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -17.938 3.516.303 -0,51 27,50 -493.295 96.698.332
2021-09-13 2021-09-13 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -21.384 3.534.241 -0,60 27,64 -591.054 97.686.421
2021-09-13 2021-09-10 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -6.771 3.555.625 -0,19 28,73 -194.531 102.153.106
2021-09-13 2021-09-10 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -6.760 3.562.396 -0,19 27,86 -188.334 99.248.353
2021-09-13 2021-09-09 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -22.725 3.569.156 -0,63 28,97 -658.343 103.398.449
2021-09-08 2021-09-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -940 3.591.881 -0,03 29,10 -27.354 104.523.737
2021-09-08 2021-09-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -11.152 3.592.821 -0,31 28,61 -319.059 102.790.609
2021-09-08 2021-09-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
J - Other -31.340 3.603.793 -0,86
2021-09-08 2021-09-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -30.474 3.635.313 -0,83 29,18 -889.231 106.078.433
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -13.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -13.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -13.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -13.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -10.000 0 -100,00
2021-07-13 2021-07-12 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -313 2.242.636 -0,01 34,10 -10.673 76.473.888
2021-07-13 2021-07-12 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -25.246 2.242.949 -1,11 33,58 -847.761 75.318.227
2021-07-13 2021-07-09 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.792 2.268.195 -0,08 33,06 -59.244 74.986.527
2021-06-30 2021-06-29 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.190 2.269.987 -0,05 33,29 -39.615 75.567.867
2021-06-30 2021-06-28 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.190 2.271.177 -0,05 34,82 -41.436 79.082.383
2021-06-30 2021-06-28 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -6.080 2.272.367 -0,27 34,06 -207.085 77.396.820
2021-06-28 2021-06-25 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -9.943 2.278.447 -0,43 33,51 -333.190 76.350.759
2021-06-28 2021-06-24 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -2.697 2.288.390 -0,12 33,53 -90.430 76.729.717
2021-06-23 2021-06-23 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -622 2.291.087 -0,03 32,98 -20.514 75.560.049
2021-06-23 2021-06-22 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -189 2.291.709 -0,01 34,09 -6.443 78.124.360
2021-06-23 2021-06-22 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.486 2.291.898 -0,06 33,36 -49.573 76.457.717
2021-06-23 2021-06-21 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -14.006 2.293.384 -0,61 34,63 -485.028 79.419.888
2021-06-23 2021-06-21 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -2.556 2.307.390 -0,11 33,80 -86.393 77.989.782
2021-06-21 2021-06-18 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.410 2.309.946 -0,06 34,03 -47.982 78.607.462
2021-06-21 2021-06-18 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -2.556 2.311.356 -0,11 33,46 -85.524 77.337.972
2021-06-21 2021-06-17 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -753 2.313.912 -0,03 34,12 -25.692 78.950.677
2021-06-21 2021-06-17 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -13.575 2.314.665 -0,58 33,78 -458.564 78.189.384
2021-06-16 2021-06-16 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.862 2.328.240 -0,08 33,33 -62.060 77.600.239
2021-06-16 2021-06-14 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -881 2.330.102 -0,04 33,09 -29.152 77.103.075
2021-06-10 2021-06-09 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -10.738 2.330.983 -0,46 34,79 -373.575 81.094.899
2021-06-10 2021-06-09 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -4.785 2.341.721 -0,20 34,42 -164.700 80.602.037
2021-06-10 2021-06-08 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -7.559 2.346.506 -0,32 33,41 -252.546 78.396.765
2021-06-10 2021-06-08 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -3.985 2.354.065 -0,17 32,80 -130.708 77.213.332
2021-06-07 2021-06-07 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -8.379 2.358.050 -0,35 32,96 -276.172 77.721.328
2021-06-07 2021-06-07 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -749 2.366.429 -0,03 32,25 -24.155 76.317.335
2021-06-07 2021-06-07 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.058 2.367.178 -0,04 30,74 -32.523 72.767.052
2021-06-07 2021-06-04 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -2.068 2.368.236 -0,09 31,28 -64.687 74.078.422
2021-06-07 2021-06-04 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -3.544 2.370.304 -0,15 30,80 -109.155 73.005.363
2021-06-07 2021-06-03 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -9.824 2.373.848 -0,41 31,92 -313.582 75.773.228
2021-06-02 2021-06-02 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -130 2.383.672 -0,01 32,42 -4.215 77.278.646
2021-06-02 2021-06-02 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -2.608 2.383.802 -0,11 31,83 -83.013 75.876.418
2021-06-02 2021-06-01 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -6.671 2.386.410 -0,28 32,50 -216.808 77.558.325
2021-06-02 2021-05-28 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -7.377 2.393.081 -0,31 32,67 -241.007 78.181.956
2021-05-27 2021-05-27 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.597 2.400.458 -0,07 33,16 -52.957 79.599.187
2021-05-27 2021-05-27 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.906 2.402.055 -0,08 32,81 -62.536 78.811.425
2021-05-27 2021-05-26 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -751 2.403.961 -0,03 33,01 -24.791 79.354.753
2021-05-27 2021-05-26 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -9.839 2.404.712 -0,41 32,74 -322.129 78.730.271
2021-05-27 2021-05-25 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -44 2.414.551 0,00 33,59 -1.478 81.104.768
2021-05-27 2021-05-25 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -2.852 2.414.595 -0,12 32,87 -93.745 79.367.738
2021-05-24 2021-05-24 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -8.219 2.417.447 -0,34 34,28 -281.747 82.870.083
2021-05-24 2021-05-24 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.563 2.425.666 -0,06 33,30 -52.048 80.774.678
2021-05-24 2021-05-21 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -133.359 2.427.229 -5,21 34,80 -4.640.893 84.467.569
2021-05-20 2021-05-20 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -265 2.560.588 -0,01 35,19 -9.325 90.107.092
2021-05-20 2021-05-20 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -4.122 2.560.853 -0,16 34,66 -142.869 88.759.165
2021-05-20 2021-05-19 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -1.939 2.564.975 -0,08 35,00 -67.865 89.774.125
2021-05-20 2021-05-19 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -4.029 2.566.914 -0,16 34,23 -137.913 87.865.466
2021-05-20 2021-05-18 4 RPTX Repare Therapeutics Inc.
Common Shares
J - Other X -21.834 2.570.943 -0,84
2021-05-20 2021-05-18 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -40 2.592.777 0,00 35,14 -1.406 91.110.184
2021-05-20 2021-05-18 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -3.763 2.592.817 -0,14 34,61 -130.237 89.737.396
2021-05-20 2021-05-18 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale X -6.509 2.596.580 -0,25 33,90 -220.655 88.024.062
2021-05-14 2021-05-13 4 RPTX Repare Therapeutics Inc.
Stock Option (right to buy)
A - Award 21.000 21.000
2021-05-06 2021-05-04 4 HOWL Werewolf Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -6.621.546 0 -100,00
2021-05-06 2021-05-04 4 HOWL Werewolf Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -19.925.321 0 -100,00
2021-05-06 2021-05-04 4 HOWL Werewolf Therapeutics, Inc.
Common Stock
P - Purchase 125.759 3.187.998 4,11 16,00 2.012.144 51.007.968
2021-05-06 2021-05-04 4 HOWL Werewolf Therapeutics, Inc.
Common Stock
C - Conversion 763.809 3.062.239 33,23
2021-05-06 2021-05-04 4 HOWL Werewolf Therapeutics, Inc.
Common Stock
C - Conversion 2.298.430 2.298.430
2021-04-15 2021-04-15 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -1.052 3.220.844 -0,03 20,49 -21.555 65.995.094
2021-04-15 2021-04-14 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -1.550 3.221.896 -0,05 20,83 -32.286 67.112.094
2021-04-15 2021-04-14 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -121 3.223.446 0,00 20,06 -2.427 64.662.327
2021-04-15 2021-04-13 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -286 3.223.567 -0,01 20,08 -5.743 64.729.225
2021-04-15 2021-04-13 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -1.657 3.223.853 -0,05 19,35 -32.063 62.381.556
2021-04-13 2021-04-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -48 3.225.510 0,00 22,68 -1.089 73.154.567
2021-04-13 2021-04-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -811 3.225.558 -0,03 21,52 -17.453 69.414.008
2021-04-13 2021-04-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -1.637 3.226.369 -0,05 20,72 -33.919 66.850.366
2021-04-13 2021-04-09 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -10.300 3.228.006 -0,32 23,67 -243.801 76.406.902
2021-04-13 2021-04-09 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -119 3.665.787 0,00 29,99 -3.569 109.936.952
2021-04-09 2021-04-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -247 3.655.906 -0,01 31,01 -7.659 113.369.645
2021-04-09 2021-04-08 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -19.057 3.666.153 -0,52 30,51 -581.429 111.854.328
2021-04-09 2021-04-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
J - Other -15.670 3.685.210 -0,42
2021-04-09 2021-04-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -777 3.700.880 -0,02 33,84 -26.294 125.237.779
2021-04-09 2021-04-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -1.842 3.701.657 -0,05 32,84 -60.491 121.562.416
2021-04-09 2021-04-07 4 ITOS iTeos Therapeutics, Inc.
Common Stock
S - Sale X -3.164 3.703.499 -0,09 32,07 -101.469 118.771.213
2021-03-16 2021-03-15 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.000.000 909.258 -52,38 25,10 -25.100.000 22.822.376
2021-03-15 2021-03-15 4 RPTX Repare Therapeutics Inc.
Common Shares
J - Other -24.271 2.603.089 -0,92
2021-03-15 2021-03-12 4 RPTX Repare Therapeutics Inc.
Common Shares
S - Sale -376.412 2.627.360 -12,53 28,18 -10.607.290 74.039.005
2021-02-12 2021-02-10 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -183.051 3.238.306 -5,35 20,00 -3.661.020 64.766.120
2021-02-09 2021-02-09 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -9.400 3.421.357 -0,27 20,25 -190.350 69.282.479
2021-02-09 2021-02-08 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -72.128 3.430.757 -2,06 20,04 -1.445.445 68.752.370
2021-02-09 2021-02-05 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -10.172 3.502.885 -0,29 20,01 -203.542 70.092.729
2021-02-04 2021-02-04 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -29.730 3.513.057 -0,84 20,37 -605.600 71.560.971
2021-02-04 2021-02-03 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -41.922 3.542.787 -1,17 20,21 -847.244 71.599.725
2021-02-04 2021-02-02 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -48.421 3.584.709 -1,33 20,13 -974.715 72.160.192
2021-01-27 2021-01-27 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -706.825 3.633.130 -16,29 20,00 -14.136.500 72.662.600
2021-01-27 2021-01-26 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -1.363 4.339.955 -0,03 21,08 -28.732 91.486.251
2021-01-27 2021-01-25 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -13.006 4.341.318 -0,30 21,23 -276.117 92.166.181
2021-01-22 2021-01-22 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -24.695 4.354.324 -0,56 21,72 -536.375 94.575.917
2021-01-22 2021-01-21 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -200 4.379.019 0,00 23,77 -4.754 104.089.282
2021-01-22 2021-01-21 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -4.887 4.379.219 -0,11 22,61 -110.495 99.014.142
2021-01-22 2021-01-21 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -20.979 4.384.106 -0,48 22,11 -463.846 96.932.584
2021-01-22 2021-01-20 4 HARP Harpoon Therapeutics, Inc.
Common Stock
J - Other X -101.646 4.405.085 -2,26
2021-01-22 2021-01-20 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -2.000 4.506.731 -0,04 24,71 -49.420 111.361.323
2021-01-22 2021-01-20 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale X -15.694 4.508.731 -0,35 23,95 -375.871 107.984.107
2020-10-08 2020-10-06 4 ONCR Oncorus, Inc.
Series B Preferred Stock
C - Conversion -775.975 0 -100,00
2020-10-08 2020-10-06 4 ONCR Oncorus, Inc.
Series A-1 Preferred Stock
C - Conversion -1.783.879 0 -100,00
2020-10-08 2020-10-06 4 ONCR Oncorus, Inc.
Common Stock
P - Purchase 173.776 2.849.453 6,49 15,00 2.606.640 42.741.795
2020-10-08 2020-10-06 4 ONCR Oncorus, Inc.
Common Stock
C - Conversion 775.975 2.675.677 40,85
2020-10-08 2020-10-06 4 ONCR Oncorus, Inc.
Common Stock
C - Conversion 1.783.879 1.899.702 1.540,18
2020-10-01 3 ONCR Oncorus, Inc.
Common Stock
115.823
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -26.176 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -70.492 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.326.313 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -275.932 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -743.076 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -13.980.992 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 91.081 91.081
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 245.279 245.279
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 4.614.943 4.614.943
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B-2 Preferred Stock
C - Conversion -29.440 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B-2 Preferred Stock
C - Conversion -79.281 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B-2 Preferred Stock
C - Conversion -1.491.666 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B-2 Preferred Stock
C - Conversion -81.295 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B-2 Preferred Stock
C - Conversion -157.529 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B-2 Preferred Stock
C - Conversion -2.361.805 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -47.674 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -128.384 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -2.415.530 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -131.645 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -255.094 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -3.824.591 0 -100,00
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
P - Purchase 1.121 25.974 4,51 19,00 21.299 493.506
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
P - Purchase 3.020 69.951 4,51 19,00 57.380 1.329.069
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
P - Purchase 56.814 1.316.139 4,51 19,00 1.079.466 25.006.641
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
P - Purchase 3.096 71.727 4,51 19,00 58.824 1.362.813
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
P - Purchase 5.994 138.985 4,51 19,00 113.886 2.640.715
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
P - Purchase 89.955 2.083.887 4,51 19,00 1.709.145 39.593.853
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 9.033 24.853 57,10
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 24.326 66.931 57,10
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 457.706 1.259.325 57,10
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 24.944 68.381 57,43
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 48.336 132.991 57,10
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 724.702 1.993.932 57,10
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 15.820 15.820
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 42.605 42.605
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 801.619 801.619
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 43.687 43.687
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 84.655 84.655
2020-07-29 2020-07-28 4 ITOS iTeos Therapeutics, Inc.
Common Stock
C - Conversion 1.269.230 1.269.230
2020-06-30 2020-06-26 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 1.909.258 -0,02 25,04 -7.512 47.807.820
2020-06-25 2020-06-23 4 RPTX Repare Therapeutics Inc.
Class B Preferred Shares
C - Conversion -952.191 0 -100,00
2020-06-25 2020-06-23 4 RPTX Repare Therapeutics Inc.
Class A Preferred Shares
C - Conversion -1.801.581 0 -100,00
2020-06-25 2020-06-23 4 RPTX Repare Therapeutics Inc.
Common Shares
P - Purchase 250.000 3.003.772 9,08 20,00 5.000.000 60.075.440
2020-06-25 2020-06-23 4 RPTX Repare Therapeutics Inc.
Common Shares
C - Conversion 952.191 2.753.772 52,85
2020-06-25 2020-06-23 4 RPTX Repare Therapeutics Inc.
Common Shares
C - Conversion 1.801.581 1.801.581
2020-06-25 2020-06-25 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -17.947 1.909.558 -0,93 25,41 -456.033 48.521.869
2020-06-25 2020-06-24 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -97.388 1.927.505 -4,81 25,34 -2.467.812 48.842.977
2020-06-18 2020-06-17 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 18.500 18.500
2020-06-12 2020-06-11 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 13.000 13.000
2020-06-05 2020-06-05 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.896 2.024.893 -0,09 20,00 -37.920 40.497.860
2020-06-03 2020-06-03 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18.245 2.026.789 -0,89 20,27 -369.826 41.083.013
2020-06-03 2020-06-02 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15.578 2.045.034 -0,76 20,23 -315.143 41.371.038
2020-06-03 2020-06-01 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10.535 2.060.612 -0,51 20,08 -211.543 41.377.089
2020-05-28 2020-05-28 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19.152 2.071.147 -0,92 20,19 -386.679 41.816.458
2020-05-28 2020-05-27 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10.148 2.090.299 -0,48 20,13 -204.279 42.077.719
2020-05-26 2020-05-26 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -44.421 2.100.447 -2,07 20,47 -909.298 42.996.150
2020-05-26 2020-05-22 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -26.906 2.144.868 -1,24 20,13 -541.618 43.176.193
2020-05-26 2020-05-21 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25.594 2.171.774 -1,16 20,25 -518.278 43.978.424
2020-05-20 2020-05-20 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10.527 2.197.368 -0,48 20,01 -210.645 43.969.334
2020-05-20 2020-05-19 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.633 2.207.895 -0,12 20,00 -52.660 44.157.900
2020-05-20 2020-05-18 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -21.349 2.210.528 -0,96 20,00 -426.980 44.210.560
2020-05-15 2020-05-13 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.837 2.231.877 -0,08 20,04 -36.813 44.726.815
2020-05-12 2020-05-12 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -24.342 2.233.714 -1,08 20,23 -492.439 45.188.034
2020-05-12 2020-05-11 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -22.155 2.258.056 -0,97 20,34 -450.633 45.928.859
2020-05-12 2020-05-08 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.633 2.280.211 -0,29 20,05 -132.992 45.718.231
2020-05-07 2020-05-07 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -200 2.286.844 -0,01 20,01 -4.002 45.759.748
2020-05-07 2020-05-06 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.626 2.287.044 -0,07 20,00 -32.520 45.740.880
2020-04-30 2020-04-29 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -20.397 2.288.670 -0,88 20,12 -410.388 46.048.040
2020-04-30 2020-04-28 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15.826 2.309.067 -0,68 20,07 -317.628 46.342.975
2020-04-01 2020-04-01 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15.462 2.324.893 -0,66 15,10 -233.476 35.105.884
2020-04-01 2020-03-31 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19.108 2.340.355 -0,81 15,16 -289.677 35.479.782
2020-03-30 2020-03-26 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.300 2.359.463 -0,10 15,04 -34.592 35.486.324
2020-03-24 2020-03-20 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.100 2.361.763 -0,05 15,00 -16.500 35.426.445
2020-03-19 2020-03-19 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.200 2.362.863 -0,35 15,07 -123.574 35.608.345
2020-03-19 2020-03-18 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12.781 2.371.063 -0,54 15,14 -193.504 35.897.894
2020-03-19 2020-03-17 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.653 2.383.844 -0,40 15,12 -145.953 36.043.721
2019-12-13 2019-12-12 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.762 2.393.497 -0,16 25,01 -94.088 59.861.360
2019-12-13 2019-12-11 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -13.600 2.397.259 -0,56 25,14 -341.904 60.267.091
2019-12-11 2019-12-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -41.839 2.410.859 -1,71 25,36 -1.061.037 61.139.384
2019-12-11 2019-12-09 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -22.195 2.452.698 -0,90 25,04 -555.763 61.415.558
2019-12-03 2019-12-03 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16.777 2.474.893 -0,67 22,33 -374.630 55.264.361
2019-12-03 2019-12-02 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25.366 2.491.670 -1,01 22,03 -558.813 54.891.490
2019-11-29 2019-11-29 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18.359 2.517.036 -0,72 22,67 -416.199 57.061.206
2019-11-29 2019-11-27 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -34.960 2.535.395 -1,36 22,91 -800.934 58.085.899
2019-11-29 2019-11-26 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -74.225 2.570.355 -2,81 23,31 -1.730.185 59.914.975
2019-11-26 2019-11-25 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -50.320 2.644.580 -1,87 23,34 -1.174.469 61.724.497
2019-11-26 2019-11-25 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -71.023 2.694.900 -2,57 23,04 -1.636.370 62.090.496
2019-11-26 2019-11-22 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.171 2.765.923 -0,04 22,04 -25.809 60.960.943
2019-11-26 2019-11-22 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -101.511 2.767.094 -3,54 21,78 -2.210.910 60.267.307
2019-11-22 2019-11-21 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.457 2.868.605 -0,19 21,09 -115.088 60.498.879
2019-11-22 2019-11-21 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -59.466 2.874.062 -2,03 20,50 -1.219.053 58.918.271
2019-11-22 2019-11-20 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -141.365 2.933.528 -4,60 22,02 -3.112.857 64.596.287
2019-06-21 2019-06-19 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2019-06-17 2019-06-13 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 13.000 13.000
2019-02-21 2019-02-19 4 TCRR TCR2 THERAPEUTICS INC.
Series B Preferred Stock
C - Conversion -2.000.000 0 -100,00
2019-02-21 2019-02-19 4 TCRR TCR2 THERAPEUTICS INC.
Series A Preferred Stock
C - Conversion -17.500.000 0 -100,00
2019-02-21 2019-02-19 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 706.666 4.050.865 21,13 15,00 10.599.990 60.762.975
2019-02-21 2019-02-19 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
C - Conversion 322.901 3.344.199 10,69
2019-02-21 2019-02-19 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
C - Conversion 2.825.396 3.021.298 1.442,25
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
X - Other -50.837 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
X - Other -50.837 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
X - Other -76.256 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
X - Other -171.579 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
X - Other -57.192 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
X - Other -25.418 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -417.852 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.578.751 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -1.525.164 0 -100,00
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
P - Purchase 250.000 4.524.425 5,85 14,00 3.500.000 63.341.950
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
S - Sale -1.524 4.274.425 -0,04 14,00 -21.336 59.841.950
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
X - Other 432.119 4.275.949 11,24 0,05 21.260 210.377
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
C - Conversion 417.852 3.843.830 12,20
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
C - Conversion 1.578.751 3.425.978 85,47
2019-02-14 2019-02-12 4 HARP Harpoon Therapeutics, Inc.
Common Stock
C - Conversion 1.525.164 1.847.227 473,56
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-13 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
391.804
2019-02-11 2018-06-25 5 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 378.501 3.074.893 14,04 26,42 9.999.996 81.238.673
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2019-02-07 3 HARP Harpoon Therapeutics, Inc.
Common Stock
644.126
2018-06-11 2018-06-07 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 13.000 13.000
2018-06-08 2018-06-06 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10.000 10.000
2017-10-11 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Series A-1 Junior Preferred Stock
C - Conversion -15.887.703 0 -100,00
2017-10-11 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Series A Preferred Stock
C - Conversion -7.651.831 0 -100,00
2017-10-11 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 100.000 2.696.392 3,85 17,00 1.700.000 45.838.664
2017-10-11 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
C - Conversion 2.567.014 2.596.392 8.737,88
2017-10-11 2017-08-18 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Series A Preferred Stock
A - Award 3.015.915 3.015.915 1,00 3.015.915 3.015.915
2017-10-04 3 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
58.756
2017-10-04 3 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
58.756
2017-06-19 2017-06-15 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 13.000 13.000
2016-09-29 2016-09-27 4 RDUS Radius Health, Inc.
Common Stock
J - Other -713.849 1.427.698 -33,33
2016-06-13 2016-06-09 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2016-03-09 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -312.085 0 -100,00
2016-03-09 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series B-1 Preferred Stock
C - Conversion -718.396 0 -100,00
2016-03-09 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series A-1 Preferred Stock
C - Conversion -1.138.210 0 -100,00
2016-03-09 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Common Stock
C - Conversion 312.085 2.168.691 16,81
2016-03-09 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Common Stock
C - Conversion 718.396 1.856.606 63,12
2016-03-09 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Common Stock
C - Conversion 1.138.210 1.138.210
2015-10-20 2015-10-20 4 CERC Cerecor Inc.
Series B Convertible Preferred Stock
C - Conversion -16.672.224 0 -100,00
2015-10-20 2015-10-20 4 CERC Cerecor Inc.
Common Stock
C - Conversion 595.436 595.436
2015-07-21 2015-07-21 4 CHMA CHIASMA, INC
Series E Preferred Stock
C - Conversion -13.000.000 0 -100,00
2015-07-21 2015-07-21 4 CHMA CHIASMA, INC
Series D' Preferred Stock
C - Conversion -16.066.669 0 -100,00
2015-07-21 2015-07-21 4 CHMA CHIASMA, INC
Series C' Preferred Stock
C - Conversion -22.721.988 0 -100,00
2015-07-21 2015-07-21 4 CHMA CHIASMA, INC
Series B-1' Preferred Stock
C - Conversion -95.225 0 -100,00
2015-07-21 2015-07-21 4 CHMA CHIASMA, INC
Common Stock
C - Conversion 1.423.566 5.681.544 33,43
2015-07-21 2015-07-21 4 CHMA CHIASMA, INC
Common Stock
C - Conversion 1.759.381 4.257.978 70,41
2015-07-21 2015-07-21 4 CHMA CHIASMA, INC
Common Stock
C - Conversion 2.488.171 2.498.597 23.865,06
2015-07-21 2015-07-21 4 CHMA CHIASMA, INC
Common Stock
C - Conversion 10.426 10.426
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series B Convertible Preferred Stock
C - Conversion -71.638 0 -100,00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -184.242 0 -100,00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -114.537 0 -100,00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
J - Other 393.802 2.141.547 22,53
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 314.204 1.747.745 21,92
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 883.993 1.433.541 160,86
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 549.548 549.548
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Common Stock (Right to Buy)
C - Conversion 37.369 37.369
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Series D Preferred Stock (Right to Buy)
C - Conversion -1.516.122 0 -100,00
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Convertible Preferred Stock
C - Conversion -10.266.940 0 -100,00
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series D Convertible Preferred Stock
C - Conversion -15.400.411 0 -100,00
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series C Convertible Preferred Stock
C - Conversion -2.947.605 0 -100,00
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series B Convertible Preferred Stock
C - Conversion -6.000.000 0 -100,00
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series A Convertible Preferred Stock
C - Conversion -20.757.635 0 -100,00
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 253.066 1.776.692 16,61
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 379.599 1.523.626 33,18
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 114.942 1.144.027 11,17
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 230.756 1.029.085 28,90
2014-04-23 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 798.329 798.329
2014-03-12 2014-03-10 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
S - Sale -600.000 2.751.048 -17,90 20,02 -12.012.000 55.075.981
2014-03-11 2014-03-07 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
S - Sale -12.539 0 -100,00 19,95 -250.153
2014-03-05 2014-03-03 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
J - Other 37.117 37.117
2014-03-05 2014-03-03 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
J - Other 12.247 12.393 8.388,36
2014-03-05 2014-03-03 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
J - Other 15.310 17.937 582,79
2014-03-05 2014-03-03 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
J - Other 20.876 22.767 1.103,97
2014-03-05 2014-03-03 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
J - Other 20.876 22.767 1.103,97
2014-03-05 2014-03-03 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
J - Other 20.876 38.386 119,22
2014-03-05 2014-03-03 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
J - Other -1.000.000 3.351.048 -22,98
2014-02-11 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -466.666 2.413.819 -16,20 29,25 -13.649.980 70.604.206
2014-02-06 2014-02-04 4 CLDN Celladon Corp
Warrant to Purchase Common Stock-Right to Buy
C - Conversion 17.517 17.517
2014-02-06 2014-02-04 4 CLDN Celladon Corp
Warrant to Purchase Series A-1 Preferred Stock-Right to Buy
C - Conversion -218.806 0 -100,00
2014-02-06 2014-02-04 4 CLDN Celladon Corp
Convertible Promissory Notes
C - Conversion -11.370 0 -100,00 8,00 -90.960
2014-02-06 2014-02-04 4 CLDN Celladon Corp
Series A-1 Convertible Preferred Stock
C - Conversion -11.788.047 0 -100,00
2014-02-06 2014-02-04 4 CLDN Celladon Corp
Common Stock
P - Purchase 111.608 1.066.775 11,68 8,00 892.864 8.534.200
2014-02-06 2014-02-04 4 CLDN Celladon Corp
Common Stock
C - Conversion 11.370 955.167 1,20 8,00 90.960 7.641.336
2014-02-06 2014-02-04 4 CLDN Celladon Corp
Common Stock
C - Conversion 943.797 943.797
2013-08-01 2013-07-30 4 CNAT Conatus Pharmaceuticals Inc
Warrant to Purchase Common Stock (Right to Buy)
C - Conversion 32.220 32.220
2013-08-01 2013-07-30 4 CNAT Conatus Pharmaceuticals Inc
Warrant to Purchase Series B Preferred Stock (Right to Buy)
C - Conversion -265.837 0 -100,00
2013-08-01 2013-07-30 4 CNAT Conatus Pharmaceuticals Inc
Series B Convertible Preferred Stock
C - Conversion -8.333.334 0 -100,00
2013-08-01 2013-07-30 4 CNAT Conatus Pharmaceuticals Inc
Common Stock
P - Purchase 165.265 1.192.080 16,09 11,00 1.817.915 13.112.880
2013-08-01 2013-07-30 4 CNAT Conatus Pharmaceuticals Inc
Common Stock
J - Other 16.716 1.026.815 1,65 11,00 183.876 11.294.965
2013-08-01 2013-07-30 4 CNAT Conatus Pharmaceuticals Inc
Common Stock
C - Conversion 1.010.099 1.010.099
2013-07-02 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
Series C Preferred Stock
C - Conversion -375.000 0 -100,00
2013-07-02 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
Series B Preferred Stock
C - Conversion -1.333.333 0 -100,00
2013-07-02 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
Series A Preferred Stock
C - Conversion -4.000.000 0 -100,00
2013-07-02 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
P - Purchase 500.000 4.351.050 12,98 6,00 3.000.000 26.106.300
2013-07-02 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
C - Conversion 225.631 3.851.050 6,22
2013-07-02 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
C - Conversion 802.246 3.625.419 28,42
2013-07-02 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock
C - Conversion 2.406.739 2.823.173 577,94
2013-06-26 3 PETX ARATANA THERAPEUTICS, INC.
Common Stock
180.505
2013-06-06 2013-06-05 4 EPZM Epizyme, Inc.
Series B Preferred Stock
C - Conversion -1.176.472 0 -100,00
2013-06-06 2013-06-05 4 EPZM Epizyme, Inc.
Series A Preferred Stock
C - Conversion -6.930.000 0 -100,00
2013-06-06 2013-06-05 4 EPZM Epizyme, Inc.
Common Stock
C - Conversion 392.156 2.880.485 15,76
2013-06-06 2013-06-05 4 EPZM Epizyme, Inc.
Common Stock
C - Conversion 2.309.998 2.488.329 1.295,34
2013-05-30 3 EPZM Epizyme, Inc.
Common Stock
178.331
2013-04-30 2013-04-23 4 RDUS Radius Health, Inc.
Common Stock Warrant
P - Purchase 179.095 179.095 6,14 1.100.001 1.100.001
2013-04-30 2013-04-23 4 RDUS Radius Health, Inc.
Series B Convertible Preferred Stock
P - Purchase 71.638 71.638 61,42 4.400.006 4.400.006
2013-03-13 2013-03-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale -500.000 2.790.479 -15,20 27,86 -13.930.000 77.742.745
2012-05-25 2012-05-23 4 ZLCS Zalicus Inc.
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
2012-02-03 2012-02-01 4 VSTM Verastem, Inc.
Seriec C Preferred Stock
C - Conversion -266.666 0 -100,00
2012-02-03 2012-02-01 4 VSTM Verastem, Inc.
Series B Preferred Stock
C - Conversion -2.500.000 0 -100,00
2012-02-03 2012-02-01 4 VSTM Verastem, Inc.
Series A Preferred Stock
C - Conversion -4.000.000 0 -100,00
2012-02-03 2012-02-01 4 VSTM Verastem, Inc.
Common Stoc
P - Purchase 100.000 2.033.333 5,17 10,00 1.000.000 20.333.330
2012-02-03 2012-02-01 4 VSTM Verastem, Inc.
Common Stock
C - Conversion 1.933.333 1.933.333
2009-12-22 3 CRXX COMBINATORX, INC
Common Stock
0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)